FFOX - ETF AI Analysis
Top Page
FundX Future Fund Opportunities ETF (FFOX)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Health Care Holdings
Several health care stocks in the top holdings have shown strong gains this year, helping support the fund’s overall performance.
Sector Diversification
The ETF spreads its investments across multiple sectors like industrials, health care, and technology, which can help reduce the impact if one industry struggles.
Positive Year-to-Date Performance
The fund has delivered a solid gain so far this year, indicating that its recent strategy and holdings have been working well overall.
Negative Factors
High Expense Ratio
The ETF charges a relatively high fee, which can eat into long-term returns compared with lower-cost alternatives.
Heavy U.S. Concentration
With most of its assets in U.S. companies, the fund offers limited geographic diversification and is highly tied to the U.S. market.
Recent Short-Term Weakness
The fund has experienced a weak recent month and includes at least one lagging top holding, which may add to short-term volatility.
FFOX vs. SPDR S&P 500 ETF (SPY)
AUM235.42M
RegionNorth America
Expense Ratio1.02%
Beta0.96
IssuerFundX
Inception DateJun 10, 2025
Dividend Yield1.7%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume19,976
30 Day Avg. Volume17,693
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.30Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering69
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FFOX Summary
The FundX Future Fund Opportunities ETF (FFOX) is an actively managed fund that looks for “future-focused” themes instead of tracking a set index. It mainly invests in smaller U.S. companies tied to big trends like new technology, health care innovation, and changing consumer habits. Some of its well-known holdings include Guardant Health and Natera. An investor might choose this ETF for growth potential and diversification across several forward-looking industries. However, because it focuses on smaller, trend-driven companies and doesn’t follow a broad market index, its price can be more volatile and may go up and down sharply.
How much will it cost me?The FundX Future Fund Opportunities ETF (FFOX) has an expense ratio of 1.00%, meaning you’ll pay $10 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on identifying and investing in sectors aligned with transformative global trends.
What would affect this ETF?FFOX's focus on transformative megatrends like technology and healthcare positions it to benefit from advancements in innovation and demographic shifts, which could drive long-term growth. However, its exposure to small- and mid-cap companies may make it more sensitive to economic downturns or interest rate hikes, which can negatively impact these sectors. Additionally, regulatory changes in healthcare or technology could pose risks to its top holdings.
FFOX Top 10 Holdings
FFOX is leaning hard into U.S. small- and mid-cap innovators, with health care and industrial tech names doing most of the heavy lifting. Halozyme, Guardant Health, and Natera are rising and helping drive the fund, reflecting its bet on cutting-edge biotech and diagnostics. On the industrial side, Carpenter Technology and Littelfuse have been steady-to-strong contributors, giving the portfolio a more grounded, manufacturing edge. Offsetting some of that strength, Mercury Systems and Globus Medical look a bit sluggish, occasionally dragging on an otherwise forward-looking, U.S.-focused thematic mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 4.55% | $10.65M | ― | ― | ― | |
| Guardant Health | 2.77% | $6.49M | $21.66B | 168.44% | 61 Neutral | |
| Natera | 2.54% | $5.95M | $47.31B | 95.32% | 73 Outperform | |
| Halozyme | 2.33% | $5.45M | $12.51B | 47.06% | 73 Outperform | |
| Everpure | 2.25% | $5.26M | $33.08B | 25.60% | 64 Neutral | |
| InterDigital | 2.00% | $4.69M | $8.72B | 17.42% | 76 Outperform | |
| FirstCash | 1.94% | $4.55M | $9.79B | 53.35% | 74 Outperform | |
| Littelfuse | 1.92% | $4.51M | $10.64B | 59.57% | 76 Outperform | |
| Globus Medical | 1.87% | $4.39M | $10.51B | 29.19% | 82 Outperform | |
| Ligand Pharma | 1.84% | $4.31M | $5.69B | 71.27% | 60 Neutral |
FFOX Technical Analysis
Neutral
―
Price Trends
29.80
Negative
29.13
Positive
28.55
Positive
Market Momentum
-0.22
Positive
41.39
Neutral
23.15
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FFOX, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 30.10, equal to the 50-day MA of 29.80, and equal to the 200-day MA of 28.55, indicating a neutral trend. The MACD of -0.22 indicates Positive momentum. The RSI at 41.39 is Neutral, neither overbought nor oversold. The STOCH value of 23.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FFOX.
FFOX Peer Comparison
Comparison Results
Performance Comparison
FFOX
FundX Future Fund Opportunities ETF
29.17
1.57
5.69%
SAMT
Strategas Macro Thematic Opportunities ETF
―
―
―
FEPI
REX FANG & Innovation Equity Premium Income ETF
―
―
―
AIPI
REX AI Equity Premium Income ETF
―
―
―
DUNK
Dana Unconstrained Equity ETF
―
―
―
GPTY
YieldMax AI & Tech Portfolio Option Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents